SUZ12 anticorps (C-Term)
Aperçu rapide pour SUZ12 anticorps (C-Term) (ABIN927773)
Antigène
Voir toutes SUZ12 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Réactivité croisée
- Souris, Boeuf (Vache)
-
Purification
- Purified
-
Immunogène
- SUZ12 antibody was raised in rabbit using the C terminal of SUZ12 as the immunogen
-
-
-
-
Indications d'application
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
SUZ12 Blocking Peptide, (ABIN938105), is also available for use as a blocking control in assays to test for specificity of this SUZ12 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- SUZ12 (SUZ12 Polycomb Repressive Complex 2 Subunit (SUZ12))
-
Autre désignation
- SUZ12
-
Sujet
- A chromosomal aberration involving SUZ12 may be a cause of endometrial stromal tumors. Translocation t (7,17)(p15,q21) with JAZF1 generates the JAZF1-SUZ12 oncogene consisting of the N-terminus part of JAZF1 and the C-terminus part of SUZ12. It is frequently found in all cases of endometrial stromal tumors, except in endometrial stromal sarcomas, where it is rarer. Synonyms: Polyclonal SUZ12 antibody, Anti-SUZ12 antibody, suppressor of zeste 12 homolog, Drosophila antibody, CHET9 antibody, JJAZ1 antibody, KIAA0160 antibody.
Antigène
-